Last reviewed · How we verify

NCT06589349

Effects of Kangaroo Care on Circadian Rhythm, Growth and Physiological Effects

Not yet recruiting NA Last updated 19 September 2024
What this trial tests

NA trial testing Kangaroo Care in Newborn; Vitality in 56 participants. Not yet recruiting.

Timeline
15 September 2024
Primary endpoint
15 April 2025
15 April 2025

Quick facts

Lead sponsorSibel Küçükoğlu
PhaseNA
StatusNot yet recruiting
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposesupportive care
Enrollment56
Start date15 September 2024
Primary completion15 April 2025
Estimated completion15 April 2025
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Sibel Küçükoğlu

Who can join

Adults 28 Weeks to 37 Weeks, any sex, with Newborn; Vitality or Sleep. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study was planned to investigate the effect of premature babies receiving regular kangaroo care in the NICU on circadian rhythm, growth and physiological parameters, and breast milk cortisol levels

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Kangaroo Care

Trials testing the same drug.

Other recruiting trials for Newborn; Vitality

Currently open trials in the same condition.

Other Sibel Küçükoğlu trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06589349.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing